Our current study disclosed that MEF2C and TRIM15 could promote invasion and metastasis through cancer-related signaling pathways: the MEF2C-activated MAPK signaling pathway and the TRIM15-activated glycosaminoglycan biosynthesis chondroitin sulfate signaling pathway (Figure 7). Here, MEF2C is linked to cancer.